Advertisement
Product › Details
CAP®GT cell line
Next higher product group | cell line/system (recombinant protein production) | |
Status | 2015-09-07 sales start | |
Organisation | Cevec Pharmaceuticals GmbH | |
Group | Danaher (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for cell line/system (recombinant protein production)
- [1] ProBioGen AG. (3/13/24). "Press Release: ProBioGen Partners with Mapp Biopharmaceutical, Inc. for Groundbreaking Development of Afucosylated Antibody against Marburg Virus Disease Using GlymaxX Technology". Berlin....
- [2] ProBioGen AG. (1/10/23). "Press Release: ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck Transposase Technology". Berlin....
- [3] Glycotope GmbH. (2/1/22). "Press Release: Glycotope to Spin-out Its Service Business to the Newly Formed FyoniBio GmbH". Berlin....
- [4] Valneva S.E.. (11/10/21). "Press Release: Valneva Announces European Commission Approval of Advance Purchase Agreement for up to 60 Million Doses of Inactivated COVID-19 Vaccine VLA2001". Saint-Herblain....
- [5] Glycotope GmbH. (9/21/20). "Press Release: DCprime and Glycotope Sign Licensing Agreement to Advance Program Combining Cancer Vaccination and Therapeutic Antibody Platforms". Leiden & Berlin....
- [6] Rentschler Biopharma SE. (5/19/20). "Press Release: Rentschler Biopharma Licenses Horizon Discovery's CHOSource Platform to Complement Cell Line Development Offering for Difficult-to-Express Proteins". Laupheim, Milford, MA & Cambridge....
- [7] ProBioGen AG. (2/25/20). "Press Release: ImmunOs Therapeutics Selects ProBioGen for Development and Large-Scale Manufacturing Services". Berlin & Schlieren....
- [8] ProBioGen AG. (11/12/19). "Press Release: DirectedLuck, a Transposase for Efficient Gene Delivery and High-Titer Cell Line Development". Berlin....
- [9] Cevec Pharmaceuticals GmbH. (4/16/19). "Press Release: Cevec Closes Major Financing Round to Further Expand and Commercialize Its Viral Vector Manufacturing Platform". Cologne....
- [10] Valerius Biopharma AG. (5/14/18). "Press Release: Catalent Biologics and Valerius Biopharma to Collaborate on Manufacture of Specialty Biosimilars". Somerset, NJ & Basel....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top